All In MedTech

FDA Clearance Tracker · P020014-S046

ESSURE SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 15, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 15, 2016

Approved

Time to decision

180 days

Received May 19, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P020014-S046
Device name
ESSURE SYSTEM
Applicant location
Berlin
Received
May 19, 2016
Decided
Nov 15, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P020014

Device type

Device class
Class III
Regulation
21 CFR 884.5380

Every decision under product code HHS

FDA's approval statement

As written in FDA's record.

Approval for changes to the physicians instructions for use and patient information booklet including a boxed warning and a patient decision checklist.

Source documents

Other decisions for Bayer Pharma AG

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.